Copyright
        ©The Author(s) 2025.
    
    
        World J Transplant. Sep 18, 2025; 15(3): 101245
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.101245
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.101245
            Table 1 Clinical characteristics of recipients and cardiac donors at the time of transplant, n (%)
        
    | Recipients | n = 279 | 
| Age (years) | 52 ± 13 | 
| Male sex | 221 (79) | 
| White | 232 (83) | 
| Black | 41 (15) | 
| Hispanic | 4 (2) | 
| Asian | 2 (1) | 
| Height (cm) | 175 ± 10 | 
| Weight (kg) | 86 ± 18 | 
| BMI (kg/m2) | 28 ± 5 | 
| Ischemic cardiomyopathy | 107 (38) | 
| Presence of left ventricular assist device/total artificial heart | 108 (39) | 
| Donors | |
| Age (years) | 34 ± 11 | 
| Age ≥ 40 years | 86 (31) | 
| Male sex | 168 (60) | 
| Height (cm) | 174 ± 10 | 
| Weight (kg) | 90 ± 22 | 
| BMI (kg/m2) | 30 ± 8 | 
| Ischemic time (minute) | 219 ± 64 | 
| Male recipient/male donor | 154 (55) | 
| Male recipient/female donor | 67 (24) | 
| Female recipient/female donor | 44 (16) | 
| Female recipient/male donor | 14 (5) | 
| Donor-recipient PHM difference | 1 ± 16 | 
| PHM difference < -15% | 31 (11) | 
            Table 2 Clinical outcomes of heart transplant recipients at 1-year and 3-year post-transplant
        
    | At transplant | 1-year post transplant (n = 260) | 3-year post-transplant (n = 230) | |
| Survival | N/A | 93% | 85% | 
| Weight (kg) | 86 ± 18 | 88 ± 19 | 91 ± 20a | 
| Body mass index | 28 ± 5 | 28 ± 5 | 29 ± 6a | 
| > 30 kg/m2 | 35% | 36% | 40% | 
| Left ventricular ejection fraction (%) | N/A | 59 ± 5 | 60 ± 6 | 
| < 50% | N/A | 2% | 2% | 
| Presence of donor specific antibodies | N/A | 23% | 26% | 
| Coronary artery vasculopathy | |||
| Grade 0 | N/A | 80% | 75% | 
| Grade 1 | N/A | 16% | 18% | 
| Grade 2-3 | N/A | 0% | 4% | 
            Table 3 Hemodynamics by right heart catheterization at 1-year and 3-year post-transplant
        
    | 1-year post transplant (n = 260) | 3-year post-transplant (n = 224) | |
| Right atrial pressure (mm Hg) | 7.2 ± 4.1 | 7.2 ± 4.2 | 
| < 10 mmHg | 76% | 72% | 
| 10-14 mmHg | 19% | 23% | 
| ≥ 15 mmHg | 5% | 5% | 
| Systolic PAP (mm Hg) | 31.6 ± 8.5 | 30.7 ± 7.6 | 
| Diastolic PAP (mm Hg) | 14.0 ± 4.7 | 14.5 ± 5.1 | 
| Mean PAP (mm Hg) | 21.4 ± 5.8 | 21.3 ± 5.7 | 
| > 20 mmHg | 52% | 55% | 
| Pulmonary capillary wedge pressure (mm Hg) | 11.8 ± 4.7 | 12.3 ± 4.7a | 
| ≤ 12 mmHg | 62% | 55% | 
| 13-17 mmHg | 26% | 30% | 
| ≥ 18 mmHg | 12% | 15% | 
| Cardiac output (L/minute) | 5.9 ± 1.4 | 5.6 ± 1.2 | 
| Cardiac index (L/minute/m2) | 2.9 ± 0.6 | 2.6 ± 0.5 | 
| Pulmonary vascular resistance (Wood units) | 1.7 ± 0.7 | 1.7 ± 0.7 | 
| > 2 Wood units | 27% | 29% | 
            Table 4 P values for multivariate analysis for correlation between clinical variables and right atrial pressure, mean pulmonary artery pressure, and pulmonary capillary wedge pressure at 1-year and 3-year post transplant
        
    | 1-year | 3-year | |||||
| RAP | Mean PAP | PCWP | RAP | Mean PAP | PCWP | |
| Recipient age | 0.524 | 0.318 | 0.485 | 0.927 | 0.054 | 0.720 | 
| Recipient BMI | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | 
| Donor age | 0.022 | 0.057 | 0.017 | 0.288 | 0.591 | 0.168 | 
| Donor BMI | 0.385 | 0.342 | 0.354 | 0.839 | 0.896 | 0.852 | 
| Ischemic time | 0.300 | 0.972 | 0.496 | 0.961 | 0.403 | 0.847 | 
| PHM difference | 0.036 | 0.120 | 0.008 | 0.455 | 0.664 | 0.377 | 
| Coronary artery vasculopathy | 0.312 | 0.076 | 0.037 | 0.443 | 0.023 | 0.237 | 
| Donor specific antibodies | 0.337 | 0.803 | 0.519 | 0.086 | 0.114 | 0.041 | 
- Citation: Rajagopalan N, Dennis DR, Akhtarekhavari J, Campbell K. Abnormal invasive hemodynamics in heart transplant recipients: A single-center, retrospective study. World J Transplant 2025; 15(3): 101245
- URL: https://www.wjgnet.com/2220-3230/full/v15/i3/101245.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i3.101245

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        